BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen YS, Sun R, Chen WL, Yau YC, Hsu FT, Chung JG, Tsai CJ, Hsieh CL, Chiu YM, Chen JH. The In Vivo Radiosensitizing Effect of Magnolol on Tumor Growth of Hepatocellular Carcinoma. In Vivo 2020;34:1789-96. [PMID: 32606148 DOI: 10.21873/invivo.11973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Woo SM, Min KJ, Kwon TK. Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells. Molecules 2020;25:E4591. [PMID: 33050112 DOI: 10.3390/molecules25194591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen YT, Lin CW, Su CW, Yang WE, Chuang CY, Su SC, Hsieh MJ, Yang SF. Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways. Biomedicines 2021;9:1295. [PMID: 34680412 DOI: 10.3390/biomedicines9101295] [Reference Citation Analysis]
3 Chen CH, Hsu FT, Chen WL, Chen JH. Induction of Apoptosis, Inhibition of MCL-1, and VEGF-A Expression Are Associated with the Anti-Cancer Efficacy of Magnolol Combined with Regorafenib in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:2066. [PMID: 33922992 DOI: 10.3390/cancers13092066] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Liu YC, Chiang IT, Chung JG, Hsieh JH, Chiang CH, Weng MC, Hsu FT, Lee YH, Chang CS, Lin SS. Therapeutic Efficacy and Inhibitory Mechanism of Regorafenib Combined With Radiation in Colorectal Cancer. In Vivo 2020;34:3217-24. [PMID: 33144426 DOI: 10.21873/invivo.12157] [Reference Citation Analysis]